Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
RXRX is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.26 since the market last closed. This is a 7.24% ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recent insider activity at Recursion Pharmaceuticals consisted of 1 tax payment transaction by Ben R Taylor totaling $18,400.36. All reported activity was a single non-anomalous transaction on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results